New Key Statistics Module, Z-Score and F-Score
NAS:LXRX Key Ratios
| Market Cap $ M | 614.54 |
| Enterprise Value $ M | 365.21 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 1.45 |
| Price/Sales | 154.55 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 2.00 |
| EPS (TTM) $ | -0.83 |
| Beneish M-Score | 12.27 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -2.06 |
| EV-to-EBITDA | -2.07 |
| PEG | -- |
| Shares Outstanding M | 361.49 |
| Net Margin (%) | -8,376.55 |
| Operating Margin % | -8,045.91 |
| Pre-tax Margin (%) | -8,376.55 |
| Quick Ratio | 15.56 |
| Current Ratio | 15.58 |
| ROA % (ttm) | -69.01 |
| ROE % (ttm) | -121.61 |
| ROIC % (ttm) | -300.92 |
| Dividend Yield % | -- |
| Altman Z-Score | -3.63 |
LXRX Number of Guru Trades
LXRX Volume of Guru Trades
Gurus Latest Trades with NAS:LXRX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:LXRX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Lexicon Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:LXRX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers